Clinical Trials Logo

Filter by:
  • Active, not recruiting  
  • Page [1]
NCT ID: NCT03744091 Active, not recruiting - Healthy Clinical Trials

Evaluation of the Pharmacokinetics of Prana P1 Capsules

Start date: July 16, 2018
Phase: Phase 1
Study type: Interventional

This is a single dose clinical trial to assess the Pharmacokinetics of two (2) dosages; 10 mg and 20mg of THC: THCa of Prana P1 bionutrients in healthy volunteers.

NCT ID: NCT02556099 Active, not recruiting - Sickle Cell Anemia Clinical Trials

EXTEND EXpanding Treatment for Existing Neurological Disease

Start date: August 2014
Phase: Phase 2
Study type: Interventional

The primary goal of the Phase II EXTEND trial is to investigate the effects of open-label hydroxyurea treatment, escalated to maximum tolerated dose, for children with Sickle Cell Anemia and either conditional (170 - 199 cm/sec) or abnormal (≥200 cm/sec) Transcranial Doppler velocities. The primary endpoint will be measured after 18 months of hydroxyurea but treatment will continue until a common study termination date.